» Articles » PMID: 22425248

Transcription Factor Foxo1 Represses T-bet-mediated Effector Functions and Promotes Memory CD8(+) T Cell Differentiation

Overview
Journal Immunity
Publisher Cell Press
Date 2012 Mar 20
PMID 22425248
Citations 166
Authors
Affiliations
Soon will be listed here.
Abstract

The evolutionary conserved Foxo transcription factors are important regulators of quiescence and longevity. Although, Foxo1 is known to be important in regulating CD8(+) T cell trafficking and homeostasis, its role in functional differentiation of antigen-stimulated CD8(+) T cells is unclear. Herein, we demonstrate that inactivation of Foxo1 was essential for instructing T-bet transcription factor-mediated effector differentiation of CD8(+) T cells. The Foxo1 inactivation was dependent on mTORC1 kinase, given that blockade of mTORC1 abrogated mTORC2-mediated Akt (Ser473) kinase phosphorylation, resulting in Foxo1-dependent switch from T-bet to Eomesodermin transcription factor activation and increase in memory precursors. Silencing Foxo1 ablated interleukin-12- and rapamycin-enhanced CD8(+) T cell memory responses and restored T-bet-mediated effector functions. These results demonstrate an essential role of Foxo1 in actively repressing effector or terminal differentiation processes to promote memory CD8(+) T cell development and identify the functionally diverse mechanisms utilized by Foxo1 to promote quiescence and longevity.

Citing Articles

Metabolic Signaling as a Driver of T Cell Aging.

Choi M, Choi S, Cho M, Kim C Immune Netw. 2025; 25(1):e14.

PMID: 40078788 PMC: 11896665. DOI: 10.4110/in.2025.25.e14.


CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms.

Kearl T, Furqan F, Shah N Cancer Metastasis Rev. 2024; 44(1):12.

PMID: 39617795 DOI: 10.1007/s10555-024-10228-0.


High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype.

Montoyo-Pujol Y, Ponce J, Delgado-Garcia S, Martin T, Ballester H, Castellon-Molla E Cancer Cell Int. 2024; 24(1):371.

PMID: 39523362 PMC: 11552348. DOI: 10.1186/s12935-024-03554-4.


JunB is required for CD8+ T cell responses to acute infections.

Sarkar S, Taira N, Hsieh T, Chien H, Hirota M, Koizumi S Int Immunol. 2024; 37(4):203-220.

PMID: 39425978 PMC: 11884676. DOI: 10.1093/intimm/dxae063.


Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1 progenitor CD8 T cells to improve immunotherapy.

Markowitz G, Ban Y, Tavarez D, Yoffe L, Podaza E, He Y Nat Immunol. 2024; 25(10):1884-1899.

PMID: 39327500 DOI: 10.1038/s41590-024-01963-1.


References
1.
Sinclair L, Finlay D, Feijoo C, Cornish G, Gray A, Ager A . Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol. 2008; 9(5):513-21. PMC: 2857321. DOI: 10.1038/ni.1603. View

2.
Paik J, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z . FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 2007; 128(2):309-23. PMC: 1855089. DOI: 10.1016/j.cell.2006.12.029. View

3.
Li Q, Rao R, Araki K, Pollizzi K, Odunsi K, Powell J . A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. Immunity. 2011; 34(4):541-53. PMC: 3083826. DOI: 10.1016/j.immuni.2011.04.006. View

4.
Chen C, Jeon S, Bhaskar P, Nogueira V, Sundararajan D, Tonic I . FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. Dev Cell. 2010; 18(4):592-604. PMC: 3031984. DOI: 10.1016/j.devcel.2010.03.008. View

5.
Intlekofer A, Takemoto N, Wherry E, Longworth S, Northrup J, Palanivel V . Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol. 2005; 6(12):1236-44. DOI: 10.1038/ni1268. View